Colorectal Cancer Immunotherapy Biomarkers for effective treatment for colorectal cancer While colorectal cancer rates are dropping overall, a worrying trend is emerging: cases are rising in adults between the ages of 20 and 50, who are not screened regularly. Given the necessity of early detection for current treatments, there is a growing need for effective treatments in advanced cases. Immunotherapy for colorectal cancer can be effective, especially in cases where tumors show high microsatellite instability. Join medical oncologist Dr. Luis Diaz Jr. of Memorial Sloan Kettering Cancer Center for a discussion of biomarkers, immunotherapies, and what patients with colorectal cancer need to know. He will be joined by Dr. Andrea Cercek of Memorial Sloan Kettering Cancer Center to answer your questions about genetic and genomic testing, treatment options, and other topics in our live Q&A. Kidney Cancer Immunotherapy Lung Cancer Immunotherapy Pancreatic Cancer Immunotherapy Prostate Cancer Immunotherapy Intro to CRI Cancer Immunotherapy Basics: Harnessing Our Immune System to Fight Cancer Clinical Trials and Cancer Immunotherapy: Accessing Promising Treatments Patient Perspectives: Immunotherapy and Clinical Trial Experiences Bladder Cancer Immunotherapy Gynecologic Cancer Immunotherapy Liver Cancer Immunotherapy Skin Cancer and Melanoma Immunotherapy Understanding and Overcoming Barriers to Accessing Cancer Care Blood Cancer Immunotherapy Breast Cancer Immunotherapy Go back to event page Go back Hosts Tamron Hall Award-Winning TV Host, Journalist, Executive Producer, and Philanthropist CRI Experts Julie Brahmer, MD Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Andrea Cercek, MD Memorial Sloan Kettering Cancer Center Luis Diaz Jr., MD Memorial Sloan Kettering Cancer Center Peter E. Fecci, MD, PhD Duke Cancer Center, DukeHealth, and Duke University Lawrence Fong, MD UCSF Helen Diller Family Comprehensive Cancer Center Matthew D. Galsky, MD The Tisch Cancer Institute Sangeeta Goswami, MD, PhD The University of Texas MD Anderson Cancer Center Elizabeth Ann Mittendorf, MD, PhD Dana-Farber/Harvard Cancer Center Kunle Odunsi, MD, PhD University of Chicago Medicine Comprehensive Cancer Center Joseph E. Ravenell, MD Perlmutter Cancer Center NYU Langone Health Marcel van den Brink, MD, PhD Memorial Sloan Kettering Cancer Center Ana I. Velázquez Mañana, MD MSc UCSF Helen Diller Family Comprehensive Cancer Center Robert H. Vonderheide, MD, DPhil University of Pennsylvania Health System Jennifer Wargo, MD, MMSc The University of Texas MD Anderson Cancer Center Jeffrey S. Weber, MD, PhD Perlmutter Cancer Center NYU Langone Health Theodore H. Welling, MD Perlmutter Cancer Center NYU Langone Health CRI ImmunoAdvocates LaToya Bolds-Johnson, PA-C, CAQ-EM Breast Cancer Advocate & Thriver Stephen Estrada Long-term Survivor of Stage 4 Colorectal Cancer Stephanie Gangi Breast Cancer Navigator Sunshine Pegues Lung Cancer Veteran John White Prostate Cancer Veteran CRI Moderators Brian Brewer Cancer Research Institute Sponsors Gold Silver Contributor Friend Host Institutions Request a clinical trials orientation appointment Request Questions? Contact[email protected]
